Julia Kharlip, MD
She/Her
Endocrinology
Accepting new patients
Sees patients age 15 and up
Penn Pituitary Center
View 1 additional location
Schedule onlineCall 800-789-7366
Penn Medicine Provider

About me

  • Medical Director, Penn Pituitary Center
  • Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)

I treat patients with pituitary and adrenal conditions. My particular interest is in Cushing's disease/syndrome. I also see young adults with childhood conditions of adrenal and pituitary glands transitioning to adult care. Additionally, I treat patients with endocrine complications of cancer therapies.

Education and training

  • Medical School: University of Michigan
  • Residency: University of Maryland Medical Center
  • Fellowship: Johns Hopkins Hospital

What my patients think about me

Average Rating

406 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
knowledgeable and professional
October 2025
dr simply refused to at least try a med i asked about. for my condition. only prescribed things i have tried in the past that did not address my health problem and were a waste of time and money. i'm feeling. that my symptoms were not heard.
October 2025
dr. kharlip is very knowledgeable & makes you feel comfortable asking questions
October 2025
excellent care for many years.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Kharlip is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Javier Javier Ocampo Mascaro,Caitlin A White and Julia Kharlip Cushing Syndrome, Evaluation , Elsevier’s Clinical Overviews: 2024

Douglas JE, Salmon MK, Kshirsagar RS, Eide JG, White C, Kharlip J, Jackson C, Lee JYK, Yoshor D, Kohanski MA, Palmer JN, Adappa ND Pituitary apoplexy is associated with concurrent or subsequent diagnosis of human immunodeficiency virus. , World J Otorhinolaryngol Head Neck Surg. 2024 Jul 16;11(3):349-352.: 2024

Nankee K Kumar 1, Ana Rivadeneira 2, Shubhasree Banerjee 3, Maria Gubbiotti 4, Daniel Yoshor 1, Christina Jackson 1, Julia Kharlip 5, Caitlin A White 5 Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab , AACE Clin Case Rep , 10: 2024,55-59

Barrette LX, Douglas J, Chorath KT, Shah M, Lu J, Newman JG, Adappa N, Kohanski M, Palmer J, Yoshor D, Lee J, White CA, Kharlip J, Rajasekaran K. Optimizing Perioperative Care in Transsphenoidal Pituitary Surgery: Considerations for Enhanced Recovery After Surgery. , J Craniofac Surg.: 2022

Ramya Sethuram, Daniel S. Guilfoil, Renee Amori, Julia Kharlip, and Karen M. Berkowitz Sheehan Syndrome: An Unusual Presentation Without Inciting Factors , Women's Health Reports, 1(1): 2020,287–292

Cho SS, Zeh R, Pierce JT, Jeon J, Nasrallah M, Adappa ND, Palmer JN, Newman, JG, White C, Kharlip J, Snyder P, Low P, Singhal S, Grady MS, Lee JYK. Folate Receptor Near-Infrared Optical Imaging Provides Sensitive and Specific Intraoperative Visualization of Nonfunctional Pituitary Adenomas , Oper Neurosurg , 16(1): 2019,59-70

Lee JYK, Cho SS, Zeh R, Pierce JT, Martinez-Lage M, Adappa ND, Palmer JN, Newman JG, Learned KO, White C, Kharlip J, Snyder P, Low PS, Singhal S, Grady MS. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging. , J Neurosurg. , 129(2): 2018,390-403

Sheldon CA, Kharlip J, Tamhankar MA. Inflammatory Orbitophathy Associated with Ipilimumab. , Ophthal Plast Reconstr Surg, 33((3S Suppl 1)): 2017,S155-S158

Guttenberg KB, Mayson SE, Sawan C, Kharlip J, Lee JY, Martinez-Lage M, Loevner LA, Ewanichak J, Grady MS, Snyder PJ. Prevalence of clinically silent corticotroph macroadenomas. , Clin Endocrinol , 85(6): 2016,874-880

Wilson MA, Guld K, Galetta S, Walsh RD, Kharlip J, Tamhankar M, McGettigan S, Schuchter LM, Fecher LA Acute visual loss after ipilimumab treatment for metastatic melanoma. , J Immunother Cancer, 18(4): 2016